Etiology and Outcomes of Thrombotic Microangiopathies
Clinical Journal of the American Society of Nephrology2019Vol. 14(4), pp. 557–566
Citations Over TimeTop 10% of 2019 papers
Guillaume Bayer, Florent Von Tokarski, Benjamin Thoreau, Adeline Bauvois, Christelle Barbet, Sylvie Cloarec, Élodie Merieau, Sébastien Lachot, Denis Garot, Louis Bernard, Emmanuel Gyan, F. Perrotin, Claire Pouplard, F. Maillot, Philippe Gatault, Bénédicte Sautenet, Emmanuel Rüsch, Matthias Büchler, Cécile Vigneau, Fádi Fakhouri, Jean‐Michel Halimi
Abstract
Secondary thrombotic microangiopathies represent the majority of thrombotic microangiopathies. Multiple thrombotic microangiopathies causes are present in one half of secondary thrombotic microangiopathies. The risks of dialysis, neurologic and cardiac complications, and death vary by the cause of thrombotic microangiopathies.
Related Papers
- → Atypical hemolytic uremic syndrome: from diagnosis to treatment(2015)35 cited
- → COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura ( TTP )(2023)3 cited
- → Purpura thrombotique thrombocytopénique (PTT) simulant une méningo-encéphalite(2012)1 cited
- → Pathology of thrombotic microangiopathy(2014)
- → Early differential diagnosis between thrombotic microangiopathy (TMA) and disseminated intravascular coagulation (DIC)(2020)